Table 2.

Criteria for screening papers

Components of the review question	Inclusion criteria	Exclusion criteria
Radical innovation	Innovation as an output in the form of a new pharmaceutical drug Frameworks based on organizational learning, strategy research, and management research theories	Process innovation Organizational innovation Frameworks based on macroeconomic or technological theories
Pharmaceutical firm	Empirical data from pharmaceutical firms Pharmaceutical firms dedicated to research and development	Contract manufacturers (CMOs) Pharmaceutical companies fully dedicated to the development and manufacturing of generics and/or biosimilars (e.g., Teva)
Firm level	Determinants of innovation at the company level (i.e., the many externally observable determinants such as firm size, ownership structure, etc.)	Determinants of innovation at the  Industry level  Intra-organizational level (e.g., organizational structures and policies)  Institutional level (e.g., appropriability regime)